474
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Generation of Genomic Deletions (of Rig-I GENE) in Goat Primary Cell Culture Using CRISPR/CAS9 Method

, , , & ORCID Icon
 

ABSTRACT

CRISPR/Cas9 system is a natural immune system in prokaryotes protecting them from infectious viral or plasmid DNA invading the cells. This RNA-guided system can act as powerful tool for introducing genomic alterations in eukaryotic cells with high efficiency. In the present study, Rig-Igene is taken as model gene to study the efficiency of CRISPR/Cas9 system induced gene deletion in primary fibroblast cell culture. Rig-I(retinoic acid-inducible gene-1) is involved in regulating immune response in mammals. In this study, we optimized the CRISPR/Cas9 method for knocking out Rig-Igene in Goat primary fibroblasts by using a NHEJ pathway. Cells were screened for inactivation of the Rig-Igene and two positive clones were found out of thirty colonies screened. Thus, cells containing Rig-Igene inactivation could be achieved by CRISPR/Cas9 in goat fibroblast cells.

Acknowledgments

Shivani Malpotra and Ashutosh Vats contributed equally to this work. We are also grateful to Dr. Feng Zhang (MIT) for generously providing (px459) V2.0 plasmid.

Supplementary

Figure 1: Transfection efficiency of Goat fibroblasts: (A) Transfection of fibroblast with GFP expression plasmid (pacgfpi-NI) for transfection duration of 6 hrs and 12 hrs. (B) Graphical representation (imagej, NIH) of transfection efficiency based on duration showing higher efficiency with 6 hrs duration than 12 hrs.

Figure 2: Transfection efficiency depending upon concentration of Lipofectamine 2000, Showing constant fluorescence from 3 μg to 5 μg concentration.

Additional information

Funding

This work was supported by the National Dairy Research Institute, Karnal.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.